About associationStakeholders & mission

Stakeholders & mission

Founded in 1998, the Swiss Biotech Association represents the Swiss biotech industry, advocates for favorable framework conditions, and facilitates access to talent, technology, and capital. Under the Swiss Biotech™ brand, it collaborates with partners and life sciences clusters worldwide to strengthen and promote the industry.

Our stakeholders

Who we support and represent

The Swiss Biotech Directory lists more than 1,700 companies, reflecting both the rapid growth, as well as the diversity of this vibrant economic sector. The Swiss biotech industry has built one of the most densely populated and comprehensive biotech ecosystems worldwide.

Highly specialized clinical research organizations, manufacturers, suppliers and technical consultants complement, support, and advise biotech companies which focus on the development of their proprietary product pipelines.

Many of the globally leading CROs and suppliers have selected Switzerland as their international headquarter, and Swiss biotech companies benefit from the proximity of Roche and Novartis and numerous international pharma companies. Increasingly, international companies select Switzerland as their hub for the production of highly complex biologics, peptides and cell products. International investors and industry specialists alike, value the numerous advantages Switzerland offers.

Our mission

Representing the interests of the industry

The Swiss Biotech Association is a non-profit, member-driven organization representing the interests of the Swiss biotech industry. Swiss biotech companies are leading the way in developing and commercializing innovative medicines, diagnostics, healthcare treatments, services and enabling technologies. Our core objective is to ensure that the value generated by the Swiss biotech industry continues to grow and that the industry contributes to the well-being of the socio-economic ecosystem thereby enabling Switzerland to be a key player at the forefront of bioscience innovation.

Developing favorable and competitive framework conditions

  • Creating awareness of the biotech industry’s needs and interests with policy makers
  • Advocating a competitive tax system alongside lean and pragmatic regulations
  • Fostering life science education, technology transfer and intellectual property

Legal framework and policies

Attracting talent, know-how and financial resources to drive innovation and growth

  • Promoting and facilitating access to funding opportunities
  • Connecting investors and attractive biotech investment opportunities
  • Facilitating access to national and international talent

Fostering networking through strategic, national and international partnerships

  • Connecting industry stakeholders and life science clusters
  • Organizing and co-promoting national and international life science events
  • Providing access to privileged information through industry platforms and working groups

Our partners

Promoting the accomplishments of the Swiss biotech industry

  • Disseminating the value-creation of Swiss biotech companies
  • Visualizing the diversity and competitiveness of Swiss biotech companies
  • Presenting innovative products and technologies and their contribution to quality of life

Swiss Biotech Success Stories

Empowering biotechs

Support across essential areas

Biotech industry segments

  • Therapeutics & medtech combination products
  • Digital & health technologies
  • Diagnostics & lab automation
  • Industrial biotech

Association chapters, managed by the Swiss Biotech Association with the support of specialists in the area of expertise, serve digital & health technologies, diagnostics & lab automation and industrial biotech, as well as legal, tax & accounting.

Cross-industry expertise

  • Financing & partnering
  • Talent
  • Translational R&D
  • Manufacturing, CMC & quality control
  • Regulatory & patient advocacy
  • Digitalization
  • Marketing & communication

Key focus areas managed by the Swiss Biotech Association team and board, with social responsibility across all of them.

Biotech industry segments and cross-industry expertiseA circle in four bands, the industry segments the association serves, crossed by eight bars, the areas of expertise that run across all of them, inside a ring of social responsibility.Social ResponsibilityFinancing & partneringTalentTranslational R&DManufacturing, CMC & quality controlRegulatory & patient advocacyDigitalizationMarketing & communicationLegal, tax & accountingBiotech industry segmentsCross-industry expertiseDiagnostics &lab automationDigital & healthtechnologiesTherapeutics &medtech combination productsIndustrialbiotechBiotech industry segments and cross-industry expertiseA circle in four bands, the industry segments the association serves, crossed by eight bars, the areas of expertise that run across all of them, inside a ring of social responsibility.Social ResponsibilityFinancing & partneringTalentTranslational R&DManufacturing, CMC & quality controlRegulatory & patient advocacyDigitalizationMarketing & communicationLegal, tax & accounting1234

Biotech industry segments

  1. 1Diagnostics & lab automation
  2. 2Digital & health technologies
  3. 3Therapeutics & medtech combination products
  4. 4Industrial biotech

Cross-industry expertise

  • Financing & partnering
  • Talent
  • Translational R&D
  • Manufacturing, CMC & quality control
  • Regulatory & patient advocacy
  • Digitalization
  • Marketing & communication
  • Legal, tax & accounting
  • Key focus areas managed by the Swiss Biotech Association team and board
  • Association chapters managed by the Swiss Biotech Association with support of specialists in the area of expertise

Our platforms

How we bring our mission to life

The Swiss Biotech Association creates platforms that benefit all Swiss biotech companies – not only its members – in financing and partnering, talent, education, branding and networking. We bring people together to shape ideal framework conditions for a vibrant Swiss biotech community and beyond.

Every platform at a glance: Platforms.

Event platforms

Face to face, peer-to-peer

Our event platforms offer networking opportunities for executives and professionals to discuss their needs in a relaxed, peer-to-peer setting. In a fast-evolving industry, face-to-face interactions accelerate innovation, strengthen partnerships and shape the future of the Swiss biotech community.

All events
  • Swiss Biotech Day

    For international networking at one of the leading global biotech conferences, with thousands of guests.

  • Swiss biotech CEO meetings

    The exclusive and informal networking event for Swiss R&D biotech CEOs.

  • Swiss biotech CFO meetings

    To openly share and discuss unique requirements as a CFO in the biotech sector.

  • Swiss biotech CMC/quality control meetings

    Enable CMC specialists to exchange experiences, avoid pitfalls and optimize manufacturing outsourcing.

  • Swiss biotech CSO/CMO meetings

    Gathering Swiss biotech CSOs to discuss R&D trends in translational medicine and share best practices.

  • Swiss biotech HR leaders meetings

    A day to shape business culture, leadership, and talent management in the biotech industry.

Annual report 2025

Continued growth and momentum

Record membership strengthens the association’s impact and influence.

The Swiss Biotech Association reached a record 659 members by the end of 2025, welcoming more than 100 new members annually for three consecutive years. This sustained growth reflects increasing trust in the association’s work, enhances its financial flexibility, and strengthens its position with policymakers and international partners.

Our members

Proud to have 659 members as of January 2026

These members benefit from a cost-effective marketing opportunity, with their logos featured on our communication tools, for a year or permanently.

  • Addex Therapeutics Ltd
  • Alentis Therapeutics AG
  • Altorfer Engineering GmbH
  • Atopia Therapeutics
  • Avance Basel GmbH
  • Basilea Pharmaceutica AG
  • BeOne Medicines I GmbH
  • Bio-Technopark Schlieren-Zürich
  • Bioark SA
  • BioConcept AG
  • Bioengineering AG
  • Biopôle SA
  • Cancer Research and Biotechnology AG
  • CDR-Life AG
  • Cetacea Clinical GmbH
  • chAIron SA
  • Choose Life BioTech SA
  • Cilatus Biopharma Consulting AG
  • CIS Biopharma AG
  • ClinOps Advisory Turner GmbH
  • CMC & More GmbH
  • CRB Group GmbH
  • CSEM
  • CTC Resourcing Solutions AG
  • Curatis Holding AG
  • CUTISS AG
  • EffRx Pharmaceuticals SA
  • Emtex AG
  • FloBiotech GmbH
  • Floratek Pharma SA
  • GALSER SA
  • Genevant Sciences GmbH
  • GenSearch Switzerland
  • Hoffmann & Partner AG
  • Innovalex Sàrl
  • InsideReg Sarl
  • Jantar GmbH
  • Kellerhals Carrard
  • Kinematica AG
  • LimmaTech Biologics AG
  • Luminance Health AG
  • Memo Therapeutics AG
  • Microsynth AG
  • Molecular Partners AG
  • MRGN Advisors Sàrl
  • NBE-Therapeutics AG
  • Neurosterix Pharma Sàrl
  • NewBiologix SA
  • Nikon Europe B.V., Amstelveen, Zweigniederlassung Schweiz (Egg/ZH)
  • Nxera Pharma Co., Ltd., Tokyo, Basel Branch
  • Onward Therapeutics SA
  • ORACTIVE Swiss AG
  • Orion Biotechnology Switzerland
  • Perseo pharma AG
  • Pharmaron, Inc.
  • Pharvaris GmbH
  • Populus Bio Sàrl
  • Promega AG
  • PSI CRO AG
  • RC Tritec AG
  • Solvias AG
  • SOTIO Biotech AG
  • Swiss Rockets AG
  • Synendos Therapeutics AG
  • Trialize AG
  • Ymmunobio AG
  • Yokogawa Innovation Switzerland GmBH

Join the Swiss Biotech Association